比斯穆和同时治疗H.的比较. 杆菌根除:一个前性的,随机的临床试验
A Oueslati1,2, G Mohamed1,2, S Bostani1,2
1Department of Gastroenterology and Hepatology, Military hospital of Tunis, Tunis, Tunisia.
Future science OA
|July 10, 2025
概括
同时进行的四重疗法 (QTC) 和基于木的四重疗法 (QTB) 在根除H. pylori方面表现出类似的疗效和安全性. 两种疗法都没有达到90%的根除基准,这表明需要改进治疗策略.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- *Helicobacter pylori* (*H. pylori*) 感染是一个全球性的健康问题.
- 在突尼斯,克拉里素耐药性 (28%) 挑战了标准的第一线并发四重疗法 (QTC) 的疗效.
- 基于石的四重疗法 (QTB) 提供了一个替代方案,但其成本和安全性需要评估.
研究的目的:
- 为了比较QTB与QTC在*H. pylori*根除方面的疗效,安全性和成本效益.
- 评估克拉里胺耐药性对治疗结果的影响.
- 为突尼斯的第一线*H. pylori*治疗提供基于证据的建议.
主要方法:
- 一项前性,随机化,开放标签研究,涉及200名以前未接受过治疗的患者.
- 患者接受了为期10天的QTB (比斯穆特,美特罗尼达,四环素,奥梅普拉) 或为期14天的QTC (阿莫西西林,克拉里素,美特罗尼达,埃索梅普拉).
- 治疗后4-6周通过尿素呼吸试验确定有效性;安全性和合规性也被评估.
主要成果:
- 治疗意图的根除率为QTC的82%和QTB的87% (p=0.29).
- 每个协议的根除率为QTC的84.53%和QTB的89.58% (p=0.39).
- 在QTB和QTC组之间,不良事件和遵守是相似的.
结论:
- 在*H. pylori*根除方面,QTB和QTC的疗效和安全性表现相似.
- 两种疗法都没有达到基准90%的根除率,这表明第一线治疗效率不足于最佳水平.
- 需要进一步的研究来优化*H. pylori*治疗方案,考虑到抗生素耐药性的增加.
相关概念视频
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
555
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
555
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
206
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
206
01:26Peptic Ulcer Disease IV: Management
148
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
148
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
573
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
573
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
702
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
702
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
530
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
530